Metrics as of 10/15/2026, 08:06 AM (Berlin time), refresh in progress.
Burning Rock Biotech Stock
Burning Rock Biotech Limited
Company data
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- Country
- China
- CEO
- Yusheng Han
- Employees
- 667
- Market cap
- $14 M
- IPO
- 12/06/2020
Headquartered in Guangzhou, China, and established in 2014, Burning Rock Biotech Limited is primarily engaged in developing and providing diagnostic solutions for cancer therapy selection within the People's Republic of China. Its operations are structured across three key segments: Central Laboratory Business,…
Burning Rock Biotech stock: price history
1D
-17.3%
1W
-16.7%
1M
+3.0%
6M
-37.6%
YTD
-36.0%
1Y
+60.6%
2Y
+340.3%
5Y
-91.0%
10Y
–
Next earnings date
Next earnings date
17/11/2026 (in 31 days)
Volatility around earnings
~24% stronger price swings than usual
Ask the agents about Burning Rock Biotech
Analyst assessment of Burning Rock Biotech
0
STRONG BUY
3
BUY
0
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 14/07/2021
Burning Rock Biotech stock metrics
P/E
-1.34
P/B
0.19
EV/EBITDA
6.65
RETURN ON EQUITY
-3.7%
NET MARGIN
-13.7%
DEBT/EQUITY
0.09
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
81.2%
FLOAT SHARES
876,463
AVG. DAILY VOLUME (30D)
50,854
Insider transactions (SEC)
Han Yusheng
Han Yusheng
Han Yusheng
Han Yusheng
Han Yusheng
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Burning Rock Biotech stock
What does Burning Rock Biotech do?
Burning Rock Biotech Limited is a company in the Healthcare sector, Medical - Diagnostics & Research industry, headquartered in China.
The CEO is Yusheng Han, the company employs around 667 people.
The IPO was on 12/06/2020; the stock trades on NASDAQ under the ticker BNR.
What do analysts say about Burning Rock Biotech stock?
3 analysts rate the stock, the consensus is Buy (as of 14/07/2021).
This is an external assessment, not a statement by Market Jury.
When does Burning Rock Biotech report next?
The next earnings date is 17/11/2026.
Around past earnings, price swings were roughly 24% stronger than usual.
Does Burning Rock Biotech pay a dividend?
No, Burning Rock Biotech currently does not pay a dividend.
Which stocks are comparable to Burning Rock Biotech?
Comparable stocks include Thermo Fisher Scientific, Danaher, Natera, Agilent Technologies, IQVIA Holdings, Waters, Illumina and IDEXX Laboratories.
How can I get Burning Rock Biotech stock analyzed?
Clicking "Analyze stock" lets five strategies assess Burning Rock Biotech against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.